What is the current Price Target for the Oculis stock?

The average Oculis target price is $38.76. This is 318.12% higher than the current stock price. The highest price target is 409.71%, the lowest is 183.28%. 12 Analysts have issued a price target Oculis 2027 .

How high will the Oculis stock rise?

No reliable answer can be given as to how high the Oculis stock will rise. The performance of stocks, including the Oculis stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Oculis stock today?

The performance of Oculis stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Oculis stock fall?

The decline in Oculis stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Oculis Forecast, price target & analysts

$9.27

1.49%

Nasdaq, Sep 25, 04:00 pm EDT. Closed.

ISIN

CH1242303498

Symbol

OCS

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Analysts Charts Ownership News Strategies

Oculis Target price 2026 - Analyst rating & recommendation

Oculis Classifications & Recommendation

Buy

93%

Hold

Oculis Price Target

Target Price	$38.76
Price	$9.27
Potential	318.12% register free of charge
Number of Estimates	12

	12 Analysts have issued a price target Oculis 2027 . The average Oculis target price is $38.76. This is 318.12% register free of charge higher than the current stock price. The highest price target is $47.25 409.71% register free of charge , the lowest is $26.26 183.28% register free of charge .
	A rating was issued by 15 analysts: 14 Analysts recommend Oculis to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Oculis stock has an average upside potential 2027 of 318.12% register free of charge . Most analysts recommend the Oculis stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-2.29	-1.91
	10.55%	16.59%
P/E		negative
EV/Sales		524.43

11 Analysts have issued a Oculis forecast for earnings per share. The average Oculis EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.29	10.55%
2026	$-1.91 16.59% unlock
2027	$-2.18 14.14% unlock
2028	$-1.99 8.72% unlock
2029	$-2.93 47.24% unlock
2030	$-2.45 16.38% unlock
2031	$-0.70 71.43% unlock
2032	$2.54 462.86% unlock
2033	$6.05 138.19% unlock

Current	-5.94	4.18%
2026	-4.86 18.21% unlock
2027	-4.25 12.55% unlock
2028	-4.66 9.65% unlock
2029	-3.16 32.19% unlock
2030	-3.78 19.62% unlock
2031	-13.33 252.65% unlock
2032	3.65 127.38% unlock
2033	1.53 58.08% unlock

Oculis...

Current Oculis Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 18 2026
JP Morgan	Locked ➜ Locked	Locked	Aug 14 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 05 2026
JP Morgan	Locked ➜ Locked	Locked	Jun 03 2026
Baird	Locked ➜ Locked	Locked	Jun 02 2026
Guggenheim	Locked ➜ Locked	Locked	Jun 01 2026
Stifel	Locked ➜ Locked	Locked	Jun 01 2026

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 18 2026
Locked JP Morgan: Locked ➜ Locked	Aug 14 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 05 2026
Locked JP Morgan: Locked ➜ Locked	Jun 03 2026
Locked Baird: Locked ➜ Locked	Jun 02 2026
Locked Guggenheim: Locked ➜ Locked	Jun 01 2026
Locked Stifel: Locked ➜ Locked	Jun 01 2026

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now